This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The Stretta endoscopic procedure was compared with two existing treatments, which were a daily proton-pump inhibitor (PPI) omeprazole 20mg and laparoscopic Nissen fundoplication, for individuals with long-term GORD. When the endoscopic or laparoscopic procedures failed, a daily PPI was used.
Location/setting
Canada/in-patient care.
Methods

Analytical approach:
A Markov model was used to synthesise the best available data from a variety of sources, including a key prospective study on the Stretta procedure (Corley, et al. 2003 , See 'Other Publications of Related Interest' below for bibliographic details). The hypothetical cohort analysis was carried out over a five-year period, and the authors stated that the perspective was that of the Canadian Ministry of Health.
Effectiveness data:
The clinical data for the effectiveness of the Stretta procedure and its comparators included measures of GORD symptom-free months, GORD relapse rates, stricture rates, and bleeding oesophageal ulcers. A literature review was undertaken, in the MEDLINE database, to retrieve relevant studies published prior to 2004. Review papers and conference abstracts were also handsearched.
Monetary benefit and utility valuations:
The published literature provided health state values for four parameters and assumptions were made by the authors for the remaining three parameters.
Measure of benefit:
The measures of benefit were symptom-free months and quality-adjusted life-years (QALYs). Discounting was applied at an annual rate of 3%.
